FDA approves first gene therapy to treat Duchenne muscular dystrophy
The U.S. Food and Drug Administration on Thursday approved the drug Elevidys (delandistrogene moxeparvovec-rokl), the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD).
Jun 26, 2023
0
1